A case study of innovating a new treatment

for Coronavirus by using Arecoline

Copyright 2020 NuTradeLLC

The following study was produced by the

NuTrade LLC Coronavirus Task Force

 

This study represents the work of hundreds of researchers from around the world and was correlated by Ehab Nazmy, a scientific researcher who has done over 30 scientific and medical FDA researching projects in the last three years. 

​

​

Other contributors to this report and the sections that apply to their input:

​

1.  国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知 (in Chinese). National Health Commission. 7 February 2020. Archived from the original on 28 February 2020. Retrieved 9 February 2020.

2. ^ Campbell C (20 January 2020). "The Wuhan Pneumonia Crisis Highlights the Danger in China's Opaque Way of Doing Things". Time. Retrieved 13 March 2020.

3. ^ Lucey D, Sparrow A (14 January 2020). "China Deserves Some Credit for Its Handling of the Wuhan Pneumonia". Foreign Policy. Retrieved 13 March 2020.

4. ^ Jump up to:a b c "Coronavirus Disease 2019 (COVID-19) Symptoms". Centers for Disease Control and Prevention. United States. 10 February 2020. Archived from the original on 30 January 2020.

5. ^ Jump up to:a b c d "Coronavirus (COVID-19) Mortality Rate". www.worldometers.info. 5 March 2020. Retrieved 23 March 2020.

6. ^ "Naming the coronavirus disease (COVID-19) and the virus that causes it". World Health Organization (WHO). Archived from the original on 28 February 2020. Retrieved 28 February 2020.

7. ^ Jump up to:a b c d Hui, D. S.; I. Azhar E.; Madani, T. A.; Ntoumi, F.; Kock, R.; Dar, O.; Ippolito, G.; Mchugh, T. D.; Memish, Z. A.; Drosten, Christian; Zumla, A.; Petersen, E. (February 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China". Int J Infect Dis. 91: 264–66. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.

8. ^ Jump up to:a b "WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization (WHO) (Press release). 11 March 2020. Retrieved 12 March2020.

9. ^ "Q&A on coronaviruses (COVID-19)". World Health Organization (WHO). Retrieved 11 March 2020.

10. ^ Jump up to:a b c "Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease". American Academy of Otolaryngology-Head and neck surgery. 22 March 2020. Archivedfrom the original on 24 March 2020. Retrieved 25 March 2020.

11. ^ Jump up to:a b "Q&A on coronaviruses". World Health Organization (WHO). Archived from the original on 20 January 2020. Retrieved 27 January 2020.

12. ^ Jump up to:a b c "Q&A on coronaviruses". World Health Organization. 11 February 2020. Retrieved 24 February 2020.

13. ^ Jump up to:a b c "Coronavirus Disease 2019 (COVID-19) - Transmission". Centers for Disease Control and Prevention. 17 March 2020. Retrieved 23 March 2020.

14. ^ "Q & A on COVID-19". European Centre for Disease Prevention and Control. Retrieved 23 March 2020.

15. ^ "New coronavirus stable for hours on surfaces". National Institutes of Health. 17 March 2020. Retrieved 23 March 2020.

16. ^ "Symptoms of Novel Coronavirus (2019-nCoV)". www.cdc.gov. 10 February 2020. Archived from the original on 30 January 2020. Retrieved 11 February 2020.

17. ^ Velavan, T. P.; Meyer, C. G. (March 2020). "The COVID-19 epidemic". Tropical Medicine & International Health. n/a (n/a): 278–80. doi:10.1111/tmi.13383. PMID 32052514.

18. ^ Jump up to:a b "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 26 March 2020.

19. ^ Jump up to:a b Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. (February 2020). "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)". Military Medical Research. 7 (1): 4. doi:10.1186/s40779-020-0233-6. PMC 7003341. PMID 32029004.

20. ^ "CT provides best diagnosis for COVID-19". ScienceDaily. 26 February 2020. Retrieved 2 March 2020.

21. ^ "Advice for public". World Health Organization (WHO). Archived from the original on 26 January 2020. Retrieved 25 February 2020.

22. ^ "Guidance on social distancing for everyone in the UK". GOV.UK. Retrieved 25 March2020.

23. ^ Jump up to:a b CDC (11 February 2020). "2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. Archived from the original on 14 February 2020. Retrieved 15 February 2020.

24. ^ "Advice for public". World Health Organization (WHO). Archived from the original on 26 January 2020. Retrieved 15 February 2020.

25. ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention(CDC). 15 February 2020. Archived from the original on 26 February 2020. Retrieved 20 February 2020.

26. ^ "Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". World Health Organization (WHO). Archived from the original on 31 January 2020. Retrieved 11 February 2020.

27. ^ Mahtani, S.; Berger, M.; O'Grady, S.; Iati, M. (6 February 2020). "Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China". The Washington Post. Archived from the original on 7 February 2020. Retrieved 11 February 2020.

28. ^ "WHO Situation Report #65" (PDF). WHO. 25 March 2020.

29. ^ Jump up to:a b c Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) (PDF) (Report). World Health Organization (WHO). 16–24 February 2020. Retrieved 21 March 2020.

30. ^ Jump up to:a b "Loss of sense of smell as marker of COVID-19 infection".

31. ^ Jump up to:a b Wei, Xiao-Shan; Wang, Xuan; Niu, Yi-Ran; Ye, Lin-Lin; Peng, Wen-Bei; Wang, Zi-Hao; Yang, Wei-Bing; Yang, Bo-Han; Zhang, Jian-Chu; Ma, Wan-Li; Wang, Xiao-Rong (26 February 2020). Clinical Characteristics of SARS-CoV-2 Infected Pneumonia with Diarrhea. Rochester, NY. SSRN 3546120 Check |ssrn= value (help).

32. ^ Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. (February 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet. 395 (10223): 507–513. doi:10.1016/S0140-6736(20)30211-7. PMID 32007143.

33. ^ Hessen MT (27 January 2020). "Novel Coronavirus Information Center: Expert guidance and commentary". Elsevier Connect. Archived from the original on 30 January 2020. Retrieved 31 January 2020.

34. ^ "Coronavirus Disease 2019 (COVID-19)—Symptoms". Centers for Disease Control and Prevention. 20 March 2020. Retrieved 21 March 2020.

35. ^ Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (February 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet. 395 (10223): 497–506. doi:10.1016/S0140-6736(20)30183-5. PMID 31986264.

36. ^ Lai, Chih-Cheng; Shih, Tzu-Ping; Ko, Wen-Chien; Tang, Hung-Jen; Hsueh, Po-Ren (1 March 2020). "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges". International Journal of Antimicrobial Agents. 55 (3): 105924. doi:10.1016/j.ijantimicag.2020.105924. ISSN 0924-8579. PMID 32081636.

37. ^ Jump up to:a b Zheng YY, Ma YT, Zhang JY, Xie X (March 2020). "COVID-19 and the cardiovascular system". Nature Reviews. Cardiology. doi:10.1038/s41569-020-0360-5. PMID 32139904.

38. ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020.

39. ^ World Health Organization (19 February 2020). "Coronavirus disease 2019 (COVID-19): situation report, 29". World Health Organization (WHO). hdl:10665/331118.

40. ^ "Q&A on coronaviruses (COVID-19): How long is the incubation period for COVID-19?". World Health Organization (WHO). Archived from the original on 20 January 2020. Retrieved 26 February 2020.

41. ^ Lauer, Stephen A.; Grantz, Kyra H.; Bi, Qifang; Jones, Forrest K.; Zheng, Qulu; Meredith, Hannah R.; Azman, Andrew S.; Reich, Nicholas G.; Lessler, Justin (10 March 2020). "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application". Annals of Internal Medicine. doi:10.7326/M20-0504. ISSN 0003-4819. PMC 7081172. PMID 32150748.

42. ^ Gorbalenya AE (11 February 2020). "Severe acute respiratory syndrome-related coronavirus—The species and its viruses, a statement of the Coronavirus Study Group". bioRxiv (preprint). doi:10.1101/2020.02.07.937862.

43. ^ "2019 Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention. 11 February 2020. Archived from the original on 7 March 2020. Retrieved 18 February 2020. The virus is thought to spread mainly from person-to-person ... through respiratory droplets produced when an infected person coughs or sneezes.

44. ^ van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. (March 2020). "Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1". The New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmc2004973. PMID 32182409.

45. ^ Jump up to:a b c d Gu, Jinyang; Han, Bing; Wang, Jian (27 February 2020). "COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission". Gastroenterology. doi:10.1053/j.gastro.2020.02.054. ISSN 0016-5085. PMID 32142785.

46. ^ Water Transmission and COVID-19 (CDC, accessed 19 March 2020)

47. ^ Letko M, Marzi A, Munster V (2020). "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses". Nature Microbiology. 5 (4): 562–569. doi:10.1038/s41564-020-0688-y. PMID 32094589.

48. ^ Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (March 2020). "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target". Intensive Care Medicine. 46 (4): 586–590. doi:10.1007/s00134-020-05985-9. PMC 7079879. PMID 32125455.

49. ^ Jump up to:a b c Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. (February 2020). "High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa". International Journal of Oral Science. 12 (1): 8. doi:10.1038/s41368-020-0074-x. PMC 7039956. PMID 32094336.

50. ^ Gurwitz D (March 2020). "Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics". Drug Development Research. doi:10.1002/ddr.21656. PMID 32129518.

51. ^ Hamming, I.; Timens, W.; Bulthuis, M. L. C.; Lely, A. T.; Navis, G. J.; Goor, H. van (2004). "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis". The Journal of Pathology. 203 (2): 631–637. doi:10.1002/path.1570. ISSN 1096-9896. PMID 15141377.

52. ^ Jump up to:a b Zhang, Wei; Du, Rong-Hui; Li, Bei; Zheng, Xiao-Shuang; Yang, Xing-Lou; Hu, Ben; Wang, Yan-Yi; Xiao, Geng-Fu; Yan, Bing; Shi, Zheng-Li; Zhou, Peng (1 January 2020). "Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes". Emerging Microbes & Infections. 9 (1): 386–389. doi:10.1080/22221751.2020.1729071. PMC 7048229. PMID 32065057.

53. ^ Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. (23 January 2020). "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin". bioRxiv (preprint). doi:10.1101/2020.01.22.914952.

54. ^ Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (17 March 2020). "The proximal origin of SARS-CoV-2". Nature Medicine: 1–3. doi:10.1038/s41591-020-0820-9. Retrieved 18 March 2020.

55. ^ Berger K (12 March 2020). "The Man Who Saw the Pandemic Coming". Nautilus. Retrieved 16 March 2020.

56. ^ Jump up to:a b c d Yanping Z, et al. (The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team) (17 February 2020). "The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)—China, 2020". China CDC Weekly. Chinese Center for Disease Control and Prevention. 2 (8): 113–122. Retrieved 18 March 2020.

57. ^ Heymann DL, Shindo N (February 2020). "COVID-19: what is next for public health?". Lancet. 395 (10224): 542–45. doi:10.1016/S0140-6736(20)30374-3. PMID 32061313.

58. ^ Davidson, Helen (13 March 2020). "First Covid-19 case happened in November, China government records show—report". The Guardian. Retrieved 21 March 2020.

59. ^ CDC (5 February 2020). "CDC Tests for 2019-nCoV". Centers for Disease Control and Prevention. Archived from the original on 14 February 2020. Retrieved 12 February 2020.

60. ^ "Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases". World Health Organization (WHO). Retrieved 13 March 2020.

61. ^ "2019 Novel Coronavirus (2019-nCoV) Situation Summary". Centers for Disease Control and Prevention. 30 January 2020. Archived from the original on 26 January 2020. Retrieved 30 January 2020.

62. ^ "Real-Time RT-PCR Panel for Detection 2019-nCoV". Centers for Disease Control and Prevention. 29 January 2020. Archived from the original on 30 January 2020. Retrieved 1 February 2020.

63. ^ "Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe". GlobeNewswire News Room. 30 January 2020. Archived from the original on 31 January 2020. Retrieved 1 February 2020.

64. ^ Brueck H (30 January 2020). "There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus". Business Insider. Archived from the original on 1 February 2020. Retrieved 1 February 2020.

65. ^ "Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases". Archived from the original on 21 February 2020. Retrieved 26 February 2020.

66. ^ Cohen J, Normile D (January 2020). "New SARS-like virus in China triggers alarm"(PDF). Science. 367 (6475): 234–35. Bibcode:2020Sci...367..234C. doi:10.1126/science.367.6475.234. PMID 31949058. Archived (PDF) from the original on 11 February 2020. Retrieved 11 February 2020.

67. ^ "Severe acute respiratory syndrome coronavirus 2 data hub". NCBI. Retrieved 4 March2020.

68. ^ Vogel, Gretchen (2020). "New blood tests for antibodies could show true scale of coronavirus pandemic". Science. doi:10.1126/science.abb8028. ISSN 0036-8075.

69. ^ Pang J, Wang MX, Ang IY, Tan SH, Lewis RF, Chen JI, et al. (February 2020). "Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review". Journal of Clinical Medicine. 9 (3): 623. doi:10.3390/jcm9030623. PMID 32110875.

70. ^ "Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic" (Press release). FDA. 21 March 2020. Retrieved 22 March 2020.

71. ^ Jump up to:a b Salehi, Sana; Abedi, Aidin; Balakrishnan, Sudheer; Gholamrezanezhad, Ali (14 March 2020). "Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients". American Journal of Roentgenology: 1–7. doi:10.2214/AJR.20.23034. ISSN 0361-803X. PMID 32174129.

72. ^ Lee, Elaine Y. P.; Ng, Ming-Yen; Khong, Pek-Lan (24 February 2020). "COVID-19 pneumonia: what has CT taught us?". The Lancet Infectious Diseases. 0 (4): 384–385. doi:10.1016/S1473-3099(20)30134-1. ISSN 1473-3099. PMID 32105641. Retrieved 13 March 2020.

73. ^ "ACR Recommendations for the use of Chest Radiography and Computed Tomography (CT) for Suspected COVID-19 Infection". American College of Radiology. 22 March 2020.

74. ^ Wiles S (9 March 2020). "The three phases of Covid-19 – and how we can make it manageable". The Spinoff. Retrieved 9 March 2020.

75. ^ Jump up to:a b c Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (March 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". Lancet. 395 (10228): 931–934. doi:10.1016/S0140-6736(20)30567-5. PMID 32164834. A key issue for epidemiologists is helping policy makers decide the main objectives of mitigation—e.g. minimising morbidity and associated mortality, avoiding an epidemic peak that overwhelms health-care services, keeping the effects on the economy within manageable levels, and flattening the epidemic curve to wait for vaccine development and manufacture on scale and antiviral drug therapies.

76. ^ Barclay E (10 March 2020). "How canceled events and self-quarantines save lives, in one chart". Vox.

77. ^ Wiles, Siouxsie (14 March 2020). "After 'Flatten the Curve', we must now 'Stop the Spread'. Here's what that means". The Spinoff. Retrieved 13 March 2020.

78. ^ Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD (March 2020). "How will country-based mitigation measures influence the course of the COVID-19 epidemic?". Lancet. 395 (10228): 931–934. doi:10.1016/S0140-6736(20)30567-5. PMID 32164834.

79. ^ Jump up to:a b c d Centers for Disease Control (3 February 2020). "Coronavirus Disease 2019 (COVID-19): Prevention & Treatment". Archived from the original on 15 December 2019. Retrieved 10 February 2020.

80. ^ World Health Organization. "Advice for Public". Archived from the original on 26 January 2020. Retrieved 10 February 2020.

81. ^ "My Hand-Washing Song: Readers Offer Lyrics For A 20-Second Scrub". NPR.org. Retrieved 20 March 2020.

82. ^ Maragakis LL. "Coronavirus, Social Distancing and Self Quarantine". www.hopkinsmedicine.org. John Hopkins University.

83. ^ Parker-Pope, Tara (19 March 2020). "Deciding How Much Distance You Should Keep". The New York Times. ISSN 0362-4331. Retrieved 20 March 2020.

84. ^ Grenfell R, Drew T (17 February 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". Science Alert. Archived from the original on 28 February 2020. Retrieved 26 February 2020.

85. ^ "When and how to use masks". World Health Organization (WHO). Retrieved 8 March2020.

86. ^ "For different groups of people: how to choose masks". NHC.gov.cn. National Health Commission of the People's Republic of China. 7 February 2020. Retrieved 22 March 2020. Disposable medical masks: Recommended for: · People in crowded places · Indoor working environment with a relatively dense population · People going to medical institutions · Children in kindergarten and students at school gathering to study and do other activities

87. ^ "Prevention of Coronavirus Disease 2019 (COVID-19)" (PDF). Centre for Health Protection. Retrieved 22 March 2020. Wear a surgical mask when taking public transport or staying in crowded places.

88. ^ Kuhakan, Jiraporn (12 March 2020). "'Better than nothing': Thailand encourages cloth masks amid surgical mask shortage". Reuters. Thailand's health authorities are encouraging people to make cloth face masks at home to guard against the spread of the coronavirus amid a shortage of surgical masks. ... The droplet from coughing and sneezing is around five microns and we have tested already that cloth masks can protect against droplets bigger than one micron.

89. ^ "Shortage of personal protective equipment endangering health workers worldwide"(Press release). WHO. 3 March 2020. Retrieved 24 March 2020.

90. ^ "Guidance against wearing masks for the coronavirus is wrong – you should cover your face - The Boston Globe". BostonGlobe.com.

91. ^ "Coronavirus Disease 2019 (COVID-19)—Prevention & Treatment". Centers for Disease Control and Prevention. U.S. Department of Health & Human Services. 10 March 2020.

92. ^ Centers for Disease Control and Prevention (11 February 2020). "What to do if you are sick with 2019 Novel Coronavirus (2019-nCoV)". Archived from the original on 14 February 2020. Retrieved 13 February 2020.

93. ^ "WHO-recommended handrub formulations". WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care. World Health Organization. 19 March 2009. Retrieved 19 March 2020.

94. ^ "Sequence for Putting On Personal Protective Equipment (PPE)" (PDF). CDC. Retrieved 8 March 2020.

95. ^ Jump up to:a b Fisher D, Heymann D (February 2020). "Q&A: The novel coronavirus outbreak causing COVID-19". BMC Medicine. 18 (1): 57. doi:10.1186/s12916-020-01533-w. PMC 7047369. PMID 32106852.

96. ^ Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. (February 2020). "Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province". Chinese Medical Journal: 1. doi:10.1097/CM9.0000000000000744. PMID 32044814.

97. ^ Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (March 2020). "Comorbidities and multi-organ injuries in the treatment of COVID-19". Lancet. Elsevier BV. 395 (10228): e52. doi:10.1016/s0140-6736(20)30558-4. PMID 32171074.

98. ^ Jump up to:a b Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (February 2020). "Clinical Characteristics of Coronavirus Disease 2019 in China". The New England Journal of Medicine. Massachusetts Medical Society. doi:10.1056/nejmoa2002032. PMID 32109013.

99. ^ Henry BM (2020). "COVID-19, ECMO, and lymphopenia: a word of caution". The Lancet Respiratory Medicine. Elsevier BV. doi:10.1016/s2213-2600(20)30119-3. ISSN 2213-2600. PMID 32178774.

100. ^ Cheng ZJ, Shan J (February 2020). "2019 Novel coronavirus: where we are and what we know". Infection. 48 (2): 155–163. doi:10.1007/s15010-020-01401-y. PMID 32072569.

101. ^ "Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected". World Health Organization (WHO). Archived from the original on 31 January 2020. Retrieved 13 February 2020.

102. ^ Farkas J (March 2020). COVID-19—The Internet Book of Critical Care (digital)(Reference manual). USA: EMCrit. Archived from the original on 11 March 2020. Retrieved 13 March 2020.

103. ^ "COVID19—Resources for Health Care Professionals". Penn Libraries. 11 March 2020. Retrieved 13 March 2020.

104. ^ AFP (19 March 2020). "Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID-19 Symptoms". ScienceAlert. Retrieved 19 March 2020.

105. ^ Day, Michael (17 March 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ. 368: m1086. doi:10.1136/bmj.m1086. PMID 32184201. Retrieved 18 March 2020.

106. ^ "Self-isolation advice - Coronavirus (COVID-19)". National Health Service (United Kingdom). 28 February 2020. Retrieved 27 March 2020.

107. ^ Day, Michael (17 March 2020). "Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists". BMJ. 368: m1086. doi:10.1136/bmj.m1086. ISSN 1756-1833. PMID 32184201.

108. ^ Research, Center for Drug Evaluation and (19 March 2020). "FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19". Drug Safety and Availability.

109. ^ "Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician". Retrieved 21 March 2020.

110. ^ "Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician". American Heart Association (Press release). 17 March 2020. Retrieved 25 March 2020.

111. ^ de Simone, Giovanni. "Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers". Council on Hypertension of the European Society of Cardiology. Retrieved 24 March 2020.

112. ^ Vetter P, Eckerle I, Kaiser L (February 2020). "Covid-19: a puzzle with many missing pieces". BMJ. 368: m627. doi:10.1136/bmj.m627. PMID 32075791.

113. ^ "Novel Coronavirus—COVID-19: What Emergency Clinicians Need to Know". www.ebmedicine.net. Retrieved 9 March 2020.

114. ^ Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN (February 2020). "Staff safety during emergency airway management for COVID-19 in Hong Kong". Lancet Respiratory Medicine. doi:10.1016/s2213-2600(20)30084-9. PMID 32105633.

115. ^ Filtering out Confusion: Frequently Asked Questions about Respiratory Protection, User Seal Check. The National Institute for Occupational Safety and Health (April 2018). Retrieved 16 March 2020.

116. ^ Proper N95 Respirator Use for Respiratory Protection Preparedness. NIOSH Science Blog (16 March 2020). Retrieved 16 March 2020.

117. ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 11 March 2020.

118. ^ "Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. 11 February 2020. Retrieved 8 March 2020.

119. ^ "Strategies for Optimizing the Supply of Eye Protection". CDC. 11 February 2020